Australia markets closed

Cellebrite DI Ltd. (CLBT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.98+0.28 (+2.01%)
At close: 04:00PM EDT
14.10 +0.12 (+0.89%)
After hours: 07:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.87B
Enterprise value 2.61B
Trailing P/E 10.08
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.84
Price/book (mrq)15.28
Enterprise value/revenue 7.59
Enterprise value/EBITDA 93.78

Trading information

Stock price history

Beta (5Y monthly) 1.50
52-week change 378.94%
S&P500 52-week change 318.96%
52-week high 314.05
52-week low 36.36
50-day moving average 311.86
200-day moving average 310.04

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 31.89M
Shares outstanding 5205.3M
Implied shares outstanding 6205.3M
Float 873.78M
% held by insiders 149.34%
% held by institutions 147.63%
Shares short (15 July 2024) 42.06M
Short ratio (15 July 2024) 41.41
Short % of float (15 July 2024) 42.02%
Short % of shares outstanding (15 July 2024) 41.00%
Shares short (prior month 14 June 2024) 42.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -33.98%
Operating margin (ttm)10.20%

Management effectiveness

Return on assets (ttm)5.58%
Return on equity (ttm)-1,768.51%

Income statement

Revenue (ttm)329.25M
Revenue per share (ttm)1.71
Quarterly revenue growth (yoy)25.90%
Gross profit (ttm)N/A
EBITDA 52.76M
Net income avi to common (ttm)-111.87M
Diluted EPS (ttm)-0.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)276.55M
Total cash per share (mrq)1.4
Total debt (mrq)12.95M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.61
Book value per share (mrq)-0.14

Cash flow statement

Operating cash flow (ttm)99.62M
Levered free cash flow (ttm)59.28M